Top Story

‘We have to cure’ cancer, says CAR T pioneer Carl H. June, MD

‘We have to cure’ cancer, says CAR T pioneer Carl H. June, MD
April 18, 2019
FDA News

FDA grants fast track designation to Annamycin for relapsed/refractory acute myeloid leukemia

April 18, 2019
The FDA granted fast track designation to Annamycin for treatment of patients with relapsed or refractory acute myeloid leukemia, according to the agent’s…

Female blood donors at risk for iron deficiency anemia

April 18, 2019
Female blood donors demonstrated an increased risk for iron deficiency anemia compared with the general population, according to study results published in…
In the Journals

Skin toxicity from anti-PD-1 therapy associated with better melanoma outcomes

April 18, 2019
Patients with advanced melanoma who experienced cutaneous toxic effects during treatment with anti-PD-1 therapy appeared to have better clinical outcomes than patients…
Meeting NewsVideo

VIDEO: Head and neck cancer landscape changing as incidence of HPV-positive disease increases

April 18, 2019
NEW YORK — Robert L. Ferris, MD, PhD, director of UPMC Hillman Cancer Center, spoke at HemOnc Today New York about management of HPV-positive oropharynx cancer…
More Headlines »

Ace the Case: A 72-Year-Old Man With Fatigue, Weight Loss, and Lymphocytosis

There is no commercial support for this activity.

This educational activity will review the diagnosis and management of a 72-year-old man with complaints of increasing…
More »
Meeting News

VIDEO: Timely biomarker work-up helps ensure optimal lung cancer treatment

April 11, 2019
More »
Resource Centers
HemOnc Today New York

HemOnc Today New York


Updates in Hematologic Malignancies: What You Might Have Missed in San Diego

This activity is supported by an educational grant from Pharmacyclics LLC.

Therapeutic options continue to expand for patients with hematologic malignancies. The clinical evaluation of novel…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next